ClinicalTrials.gg
CompletedNCT07884630Updated Oct 20, 2026

Horizontal Ridge Augmentation in Atrophic Posterior Mandible With Delayed Implant Placement

An interventional study of atrophied ridge augmentation in Atrophic Mandible, sponsored by Mansoura University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 2 years 11 months after the study started (first participant enrolled Nov 2023, registered Oct 2026).
Updated Oct 20, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The study will assess the clinical and radiographic outcomes of tenting pole technique versus modified tunneling technique used for horizontal augmentation of atrophied posterior mandibular ridge associated with delayed implant placement.

Read the detailed description

Clinically, the greatest loss of the alveolar ridge is usually in the horizontal dimension.1 Horizontal bone augmentation is a necessary and indispensable procedure for successful implant placement in a narrow alveolar ridge. A variety of reconstructive approaches have been introduced in order to obtain adequate bone volume prior to implant placement such as guided bone regeneration (GBR),2 ridge split/expansion,3 block grafting,4 tenting pole technique5 and tunneling technique.6

Autogenous block grafting or onlay bone grafts harvested either extraorally from the hip, tibia, clavarium and iliac crest or intraorally from maxillary tuberosity, symphysis of the chin, mandibular ramus and external oblique ridge. All these methods are associated with morbidity of donor sites, resorption of materials, and increased treatment costs. Hence various alternative procedures were developed to minimize this morbidity.3

On the other hand, splitting and expanding the edentulous ridge for bone augmentation and implant placement was considered as an innovative technique as it avoids the need for a second surgical site which further reduces the ailment of the patient.7 Historically bone splitting technique is used to increase the width of bone by splitting and expansion of the existing residual ridge.8 Bone splitting technique was developed by Simion et al.9 and Scipioni et al.8 In the early 1990s. Simion et al.9 aimed at originating a ''self-space making defect'' by separating the buccal cortical bone of narrow alveolar crests in two parts through a longitudinal greenstick fracture to create a gap for dental implants insertion.

GBR has demonstrated a predictable result in lateral augmentation and long-term implant success. To avoid shrinkage resulting from pressure after flap closure, several space-maintenance modalities were used to facilitate formation of reconstructed ridge such as tenting screws,10 titanium (Ti) meshes,11 and Ti-reinforced polytetrafluoroethylene (PTFE) membranes.12

Basically nonresorbable membranes have a high risk of exposure, necessitating removal in the re-entry stage.12 Incontrary, resorbable membranes have shown better biocompatibility and support of underneath bone growth.13 However, their lack of stiffness can lead to decreased bone volume gain. Therefore, the tent-pole technique, which combines resorbable collagen membrane and tenting screws, represents an effective approach, offering easy manipulation and low complication rates. 13

Tenting of mucoperiosteum has shown good potential in the rehabilitation of atrophied alveolar ridges. Expansion of the soft tissue with the use of titanium mini-screws and guided bone regeneration was introduced by Bash Le et al., 2010.10 They evaluated "the use of titanium screws in tenting fashion that was surrounded by particulate human mineralized allograft to reconstruct large mandibular defects before implant placement".

One of the techniques of guided bone regeneration is subperiosteal tunneling, suggested by Kent et al.14 In this technique, two vertical incisions are created in the ridge, and the area between them is totally detached, forming a tunnel. The graft material is positioned, and the area is sutured.15,16This allows the bone graft to be covered by an intact periosteum.17 Because of its minimal invasiveness, this technique has a shorter surgical time and lower postoperative morbidity.18-20

However, subperiosteal tunneling technique is a partially blind procedure that requires patience and delicate surgical maneuvers to develop the subperiosteal flap that could form a pocket for graft materials. Though this bone augmentation does not permit a direct view of the deficient ridge. Meanwhile, it has advantages of less postoperative complications such as less bleeding, discomfort, bone loss, and surgery recovery time. Moreover, augmentation without application of fixation is still controversial.21,22

According to forementioned data, this study will be directed to assess the clinical and radiographic outcomes of tenting pole technique versus modified tunneling technique used for horizontal augmentation of atrophied posterior mandibular ridge associated with delayed implant placement.

02

Conditions studied

  • Atrophic Mandible

Keywords

  • atrophied ridge
  • augmentation
  • dental implant
03

In context

Lead sponsor

Mansoura University is the lead sponsor of 1,115 studies on the registry; 184 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1. Patient age 18-45 years old. 2. Cooperative patient with high motivation and acceptable oral hygiene. 3. Mandibular posterior narrow ridge with width 3-5 mm bucco-lingually. 4. Bone height allowing the insertion of at least 8 mm of implant length without the need for vertical augmentation.

    5. No deep undercut at the ridge in the buccal aspect. 6. Presence of enough amount of keratinized gingiva. 7. Favorable occlusion and no parafunctional habits. 8. Patients able to comply with the required recall visits.

Exclusion criteria

Exclusion Criteria:

  • 1. General contraindications for dental and/or surgical treatments. \ 2. Concurrent or previous radiotherapy of head area. 3. Smokers. 4. Pregnancy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Other
    ridge splitting

    ridge splitting and expansion for lower posterior atrophied ridge and implant placement after 6 months

    Procedure: atrophied ridge augmentation

  • Other
    tenting pole technique

    tenting pole technique for lower posterior atrophied ridge and implant placement after 6 months

    Procedure: atrophied ridge augmentation

  • Other
    tunnling technique

    tunnling technique for lower posterior atrophied ridge and implant placement after 6 months

    Procedure: atrophied ridge augmentation

Interventions

  • Procedureatrophied ridge augmentation

    non invasive ridge augmentation techniques

06

What researchers measure

Primary outcomes

  1. bone width gain and loss

    \- Bone width of the surgical site (alveolar bone) will be measured for every planed implant site from the outermost buccal surface of bone to the outermost lingual surface of bone at four different levels - alveolar bone crest, 2mm, 4mm and at 6mm apical to the crest.

    Time frame: 6 months after augmentation and 6 months after implant placement

07

Study locations

1 site
  • Dentistry
    Al Mansurah, Egypt
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Nov 2023 to primary completion in Jan 2025, 14 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2026
First posted
Oct 20, 2026
StartActual
Nov 1, 2023
Primary completionActual
Jan 20, 2025
CompletionActual
Mar 5, 2025
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07884630
Responsible party
Sponsor
First posted
Oct 20, 2026
Start date
Nov 1, 2023
Primary completion
Jan 20, 2025
Completion
Mar 5, 2025
Last update
Oct 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion